NCT04723563View on ClinicalTrials.gov

Nebulized Heparin for the Treatment of COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

August 23, 2021

Study Completion Date

August 23, 2021

Conditions
Covid19Pneumonia, Viral
Interventions
DRUG

Heparin

25,000 units of unfractionated heparin nebulized 4 times daily for the duration of hospitalization

DRUG

0.9%sodium chloride

5 mL of 0.9% sodium chloride nebulized 4 times daily for the duration of hospitalization

Trial Locations (1)

21701

Frederick Health Hospital, Frederick

Sponsors

Lead Sponsor

Frederick Health
All Listed Sponsors
lead

Frederick Health

OTHER